ClearPoint Neuro Inc vs Prospect Capital Corporation — how do they compare? ClearPoint Neuro Inc trades at $14.84 (market cap $454.21M), while Prospect Capital Corporation trades at $2.29 (market cap $1.14B). The key difference: Prospect Capital Corporation is far larger — about 2.5× ClearPoint Neuro Inc's market cap, and Prospect Capital Corporation pays a 21.93% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | PSEC | |
|---|---|---|
Market Cap | $454.21M | $1.14B |
Sector | Health | Financials |
52-Week High | $29.60 | $3.05 |
52-Week Low | $8.66 | $2.11 |
Enterprise Value | $488.79M | — |
Dividend Yield | — | 21.93% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PSEC trades at $2.29, down 1.72% on the day, with a mixed technical picture showing a bullish moving average signal but neutral oscillators. The stock carries a low P/B of 0.39 and has beaten earnings estimates for three consecutive quarters, though it reported a net loss of $469.92 million in 2025. Recent news includes a dividend increase announcement and the sale of portfolio company Valley Electric for $328 million.
The outlook is cautious; while the deep discount to book value and consistent dividend payments offer income appeal, significant negative revenue and net income margins, alongside a divided analyst consensus, highlight substantial business and market risks. The primary opportunity lies in a potential valuation recovery if operational performance improves.
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →